Paclitaxel Resistance Related to Nuclear Envelope Structural SturdinessRunning Title: Lamin A/C Expression and Paclitaxel Resistance
出版年份 2022 全文链接
标题
Paclitaxel Resistance Related to Nuclear Envelope Structural SturdinessRunning Title: Lamin A/C Expression and Paclitaxel Resistance
作者
关键词
-
出版物
DRUG RESISTANCE UPDATES
Volume -, Issue -, Pages 100881
出版商
Elsevier BV
发表日期
2022-10-15
DOI
10.1016/j.drup.2022.100881
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
- (2021) Luciana Mosca et al. DRUG RESISTANCE UPDATES
- Therapeutic strategies to overcome taxane resistance in cancer
- (2021) Tuyelee Das et al. DRUG RESISTANCE UPDATES
- Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity
- (2021) Elizabeth R. Smith et al. MOLECULAR AND CELLULAR BIOLOGY
- A Compressive Review about Taxol®: History and Future Challenges
- (2020) Julia Gallego-Jara et al. MOLECULES
- The Role of Phosphatases in Nuclear Envelope Disassembly and Reassembly and Their Relevance to Pathologies
- (2019) Florentin Huguet et al. Cells
- Protein phosphatases at the nuclear envelope
- (2018) Raquel Sales Gil et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- New biological research and understanding of Papanicolaou's test
- (2018) Elizabeth R. Smith et al. DIAGNOSTIC CYTOPATHOLOGY
- Recent advances in microtubule-stabilizing agents
- (2018) Ya-Nan Cao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PP2A-B55 promotes nuclear envelope reformation after mitosis in Drosophila
- (2018) Haytham Mehsen et al. JOURNAL OF CELL BIOLOGY
- Defective Nuclear Lamina in Aneuploidy and Carcinogenesis
- (2018) Elizabeth R. Smith et al. Frontiers in Oncology
- Fighting tubulin-targeting anticancer drug toxicity and resistance
- (2017) Roberta Visconti et al. ENDOCRINE-RELATED CANCER
- Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
- (2017) Jue Shi et al. ENDOCRINE-RELATED CANCER
- Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer
- (2017) C Hardin et al. EXPERT OPINION ON PHARMACOTHERAPY
- An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
- (2017) Amelia L. Parker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Towards an understanding of the isotype-specific functions of tubulin in neurons: Technical advances in tubulin expression and purification
- (2017) Itsushi Minoura NEUROSCIENCE RESEARCH
- Bursting the Bubble – Nuclear Envelope Rupture as a Path to Genomic Instability?
- (2017) Pragya Shah et al. TRENDS IN CELL BIOLOGY
- Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
- (2017) T. J. Mitchison et al. Open Biology
- Lamin A and microtubules collaborate to maintain nuclear morphology
- (2017) Zeshan Tariq et al. Nucleus
- Lamin A and microtubules collaborate to maintain nuclear morphology
- (2017) Zeshan Tariq et al. Nucleus
- Optimal primary therapy of ovarian cancer: Table 1.
- (2016) M. A. Bookman ANNALS OF ONCOLOGY
- Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis
- (2016) Callinice D. Capo-chichi et al. BMC CELL BIOLOGY
- Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer
- (2016) Radmila Lemstrova et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Microtubule-stabilizing agents: New drug discovery and cancer therapy
- (2016) Ying Zhao et al. PHARMACOLOGY & THERAPEUTICS
- Linking Micronuclei to Chromosome Fragmentation
- (2015) Emily M. Hatch et al. CELL
- AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation
- (2015) A S Naeem et al. CELL DEATH AND DIFFERENTIATION
- CCR 20th Anniversary Commentary: BMS-247550--Microtubule Stabilization as Successful Targeted Therapy
- (2015) N. Pabla et al. CLINICAL CANCER RESEARCH
- Dose-dense Paclitaxel in Advanced Ovarian Cancer
- (2015) A. Kumar et al. CLINICAL ONCOLOGY
- Taxane anticancer agents: a patent perspective
- (2015) Iwao Ojima et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Class III β-tubulin in normal and cancer tissues
- (2015) Marisa Mariani et al. GENE
- Microtubule-Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer Chemotherapy
- (2015) Songbo Xie et al. MEDICINAL RESEARCH REVIEWS
- Albumin-bound paclitaxel in solid tumors: clinical development and future directions
- (2015) Madappa Kundranda et al. Drug Design Development and Therapy
- Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation Therapy
- (2015) Anna Barbuti et al. Cancers
- Taxanes, past, present, and future impact on non-small cell lung cancer
- (2014) Monika Joshi et al. ANTI-CANCER DRUGS
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling
- (2014) Xin Cai et al. MOLECULAR CELL
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression
- (2013) Jessika Bertacchini et al. FASEB JOURNAL
- The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions
- (2013) Erica Gornstein et al. NEUROPHARMACOLOGY
- Inhibitors Targeting Mitosis: Tales of How Great Drugs against a Promising Target Were Brought Down by a Flawed Rationale
- (2012) E. Komlodi-Pasztor et al. CLINICAL CANCER RESEARCH
- Connecting the nucleus to the cytoskeleton by SUN–KASH bridges across the nuclear envelope
- (2012) Erin C Tapley et al. CURRENT OPINION IN CELL BIOLOGY
- Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?
- (2012) Diana P English et al. Expert Review of Anticancer Therapy
- Transient nuclear envelope rupturing during interphase in human cancer cells
- (2012) Jesse D. Vargas et al. Nucleus
- Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer
- (2011) Callinice D Capo-chichi et al. BMC Medicine
- Weekly paclitaxel in ovarian cancer—the latest success story
- (2011) A. Jain et al. Current Oncology
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer
- (2011) Callinice D. Capo-chichi et al. Chinese Journal of Cancer
- Weekly paclitaxel in the treatment of recurrent ovarian cancer
- (2010) Richard D. Baird et al. Nature Reviews Clinical Oncology
- How do anti-mitotic drugs kill cancer cells?
- (2009) K. E. Gascoigne et al. JOURNAL OF CELL SCIENCE
- Treatment for Recurrent Ovarian Cancer—At First Relapse
- (2009) Kimio Ushijima Journal of Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started